Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Targeted Oncology|July 23, 2020
Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKIChi-Lu Chiang, Hsu-Ching Huang, Chia-I Shen, et al.Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicityChao-Hua Chiu, Chun-Ming Tsai, Yuh-Min Chen, et al.Lung Cancer (Amsterdam, Netherlands)|April 24, 2007
Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinibChao-Hua Chiu, Yu-Ning Shih, Chun-Ming Tsai, et al.Journal of the Chinese Medical Association : JCMA|April 3, 2016
Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancerChi-Lu Chiang, Yi-Wei Chen, Mei-Han Wu, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|May 17, 2005
IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cellsKuo-Ting Chang, Chun-Ming Tsai, Yih-Chy Chiou, et al.Oncotarget|April 1, 2015
MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinomaChao-Hua Chiu, Hsiang-Ling Ho, Howard Doong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2012
Gefitinib enhances cytotoxicities of antimicrotubule agents in non-small-cell lung cancer cells exhibiting no sensitizing epidermal growth factor receptor mutationChun-Ming Tsai, Chao-Hua Chiu, Kao-Ting Chang, et al.The Journal of Thoracic and Cardiovascular Surgery|June 28, 2003
Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary reportChao-Hua Chiu, Ming-Sheng Chern, Mei-Han Wu, et al.Blood|October 19, 2010
Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWISTChih-Chien Tsai, Yann-Jang Chen, Tu-Lai Yew, et al.Japanese Journal of Clinical Oncology|November 24, 2005
Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancerChun-Liang Lai, Chun-Ming Tsai, Chao-Hua Chiu, et al.Pageof 10